WELCURE

WELCURE DRUGS & PHARMACEUTICALS

Small Cap BSE: 524661 NSE: WELCURE
₹8.83
-0.46 (-4.95%)
As on 07 October, 2022 | 19:06

Welcure Drugs & Pharmaceuticals Share Price

Welcure Drugs & Pharmaceuticals Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in WELCURE DRUGS & PHARMACEUTICALS

Start SIP

Welcure Drugs & Pharmaceuticals Share Returns

  • Over 1 Month 17.48%
  • Over 3 Month 18.11%
  • Over 6 Month -13.12%
  • Over 1 Year -7.41%

Welcure Drugs & Pharmaceuticals Key Statistics

Welcure Drugs & Pharmaceuticals Investment Rating

  • Master Rating:
  • Welcure Drugs & Pharms. has an operating revenue of Rs. 0.17 Cr. on a trailing 12-month basis. An annual revenue de-growth of -15% needs improvement, Pre-tax margin of 22% is great, ROE of 25% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. From an O'Neil Methodology perspective, the stock has an EPS Rank of 18 which is a POOR score indicating inconsistency in earnings, a RS Rating of 57 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 151 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Welcure Drugs & Pharmaceuticals Financials
IndicatorJun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 000000
Operating Expenses Qtr Cr 000000
Operating Profit Qtr Cr 000000
Depreciation Qtr Cr 000000
Interest Qtr Cr 000000
Tax Qtr Cr 000000
Net Profit Qtr Cr 000000

Welcure Drugs & Pharmaceuticals Technicals

EMA & SMA

Current Price
8.87
-0.42 (-4.52%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 8.99
  • 50 Day
  • 8.41
  • 100 Day
  • 8
  • 200 Day
  • 7.68
  • 20 Day
  • 9.06
  • 50 Day
  • 8.24
  • 100 Day
  • 7.54
  • 200 Day
  • 7.67

Welcure Drugs & Pharmaceuticals Resistance and Support

PIVOT
₹9.51
Resistance
First Resistance 9.73
Second Resistance 10.17
Third Resistance 10.39
RSI 50.44
MFI 73.97
MACD Single Line 0.38
MACD 0.31
Support
First Resistance 9.07
Second Resistance 8.85
Third Resistance 8.41

Welcure Drugs & Pharmaceuticals Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 220,077 14,144,349 64.27
Week 365,719 22,341,743 61.09
1 Month 741,741 41,626,497 56.12
6 Month 255,707 15,971,437 62.46

Welcure Drugs & Pharmaceuticals Result Highlights

Welcure Drugs & Pharmaceuticals Synopsis

BSE-Medical-Biomed/Biotech

Welcure Drugs & is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company’s Total Operating Revenue is Rs. 0.11 Cr. and Equity Capital is Rs. 12.12 Cr. for the Year ended 31/03/2022. Welcure Drugs & Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 06/08/1996 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L24232DL1996PLC227773 and registration number is 227773.
Market Cap 12
Sales 0
Shares in Float 1.35
No of funds 1
Yield
Book Value 116.13
U/D Vol ratio 3.2
LTDebt / Equity
Alpha 0.08
Beta 0.48

Welcure Drugs & Pharmaceuticals

Owner NameJun-22Mar-22Dec-21
Promoters 14.12%14.12%14.12%
Financial Institutions/ Banks 0.01%0.01%0.01%
Individual Investors 76.91%76.04%76.27%
Others 8.96%9.83%9.6%

Welcure Drugs & Pharmaceuticals Management

Name Designation
Mr. Sudhir Chandra Managing Director
Mr. Dharam Chand Jain Non Executive Director
Mr. Murari Lal Bhateja Independent Director
Mr. Gagan Juneja Independent Director
Ms. Mitashi Bisaria Non Executive Director

Welcure Drugs & Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Welcure Drugs & Pharmaceuticals Corporate Action

Date Purpose Remarks
2022-10-08 Quarterly Results
2022-07-16 Quarterly Results
2022-04-15 Audited Results
2022-01-22 Quarterly Results
2021-10-25 Quarterly Results

Welcure Drugs & Pharmaceuticals FAQs

What is Share Price of Welcure Drugs & Pharmaceuticals ?

Welcure Drugs & Pharmaceuticals share price is ₹8 As on 07 October, 2022 | 18:52

What is the Market Cap of Welcure Drugs & Pharmaceuticals ?

The Market Cap of Welcure Drugs & Pharmaceuticals is ₹11.9 Cr As on 07 October, 2022 | 18:52

What is the P/E ratio of Welcure Drugs & Pharmaceuticals ?

The P/E ratio of Welcure Drugs & Pharmaceuticals is -1216.3 As on 07 October, 2022 | 18:52

What is the PB ratio of Welcure Drugs & Pharmaceuticals ?

The PB ratio of Welcure Drugs & Pharmaceuticals is 104.2 As on 07 October, 2022 | 18:52

Q1FY23